2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Nasopharyngeal Carcinoma
8
Lung Neoplasms
7
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Melanoma
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Sarcoma
2
Osteosarcoma
2
Nasopharyngeal Neoplasms
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Esophageal Neoplasms
2
Unresectable Non-small Cell Lung Cancer
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Radiation Injuries
1
Quality of Life
1
Pleural Effusion, Malignant
1
Non-squamous Non-small Cell Lung Cancer
1
Neuroblastoma
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Esophageal
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bone Neoplasms
1
Advanced Pancreatic Cancer
1
Interventions
Oxaliplatin
4
Cetuximab
4
regorafenib
3
Irinotecan
3
trifluridine tipiracil drug combination
2
surufatinib
2
Fluorouracil
2
Drug Therapy
2
Capecitabine
2
Bevacizumab
2
raltitrexed
1
plocabulin
1
paclitaxel poliglumex
1
nimotuzumab
1
endostar protein
1
durvalumab
1
defactinib
1
aflibercept
1
Panitumumab
1
N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide
1
HMPL-013
1
Folfox protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Colorectal Cancer
×
endostar protein
×
Clear all
NCT00853684
2009-09-18
OXCE
Shanghai Jiao Tong University School of Medicine
Phase 2
Unknown
44 enrolled